Page 223 - HIV/AIDS Guidelines
P. 223
IL interleukin
IL-2 interleukin-2
IL-6 interleukin-6
IL-7 interleukin-7
IND investigational new drug
INH isoniazid
inj injection
INR international normalized ratio
INSTI integrase strand transfer inhibitor
IQ inhibitory quotient
IRB Institutional Review Board
IRIS immune reconstitution inflammatory syndrome
IUD intrauterine device
LDL low-density lipoprotein
LPV lopinavir
LPV/r lopinavir/ritonavir
LTBI latent tuberculosis infection
MAC Mycobacterium avium complex
MDMA methylenedioxymethamphetamine
mDOT modified directly observed therapy
MDR multidrug-resistant
MDRD modification of diet in renal disease (equation)
MHC major histocompatability complex
MI myocardial infarction
msec millisecond
MSM men who have sex with men
MTB Mycobacterium tuberculosis
MTCT mother-to-child transmission
MVC maraviroc
NA-ACCORD The North American AIDS Cohort Collaboration on Research and Design
NFV nelfinavir
NIH National Institutes of Health
NNRTI non-nucleoside reverse transcriptase inhibitor
NRTI nucleoside reverse transcriptase inhibitor
NVP nevirapine
Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents N-4
Downloaded from http://aidsinfo.nih.gov/guidelines on 12/8/2012 EST.
